There is an opportunity for biotech-style rewards hiding in an unexpected place: big pharma. Bristol-Myers Squibb and Celgene are set to close their $74 billion ...
Updated: 09/24/2019 04:23P
When I ran into Nicole Dieker at FinCon, the annual conference of personal finance bloggers, the freelance writer and editor of the now-defunct website the ...
Updated: 09/09/2019 03:00A